🔗 Share this article

The prestigious award in medical science was granted for revolutionary findings that clarify how the body's defense network targets dangerous infections while sparing the body's own cells.

A trio of renowned researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this honor.

The research uncovered unique "sentinels" within the defense system that remove rogue immune cells that could attacking the body.

The discoveries are now enabling new treatments for immune disorders and malignancies.

The winners will divide a prize fund valued at 11m Swedish kronor.

Decisive Findings

"The work has been essential for comprehending how the immune system operates and why we don't all develop severe self-attack conditions," commented the head of the award panel.

This trio's research address a fundamental mystery: In what way does the immune system protect us from countless infections while keeping our healthy cells intact?

Our immune system uses immune cells that search for indicators of disease, including pathogens and germs it has not met before.

These defenders employ sensors—called recognition units—that are generated randomly in a vast number of combinations.

That gives the immune system the capacity to combat a broad range of invaders, but the unpredictability of the mechanism inevitably creates immune cells that may attack the host.

Security Guards of the Immune System

Scientists previously knew that a portion of these problematic defense cells were destroyed in the immune organ—where white blood cells develop.

The latest award honors the identification of regulatory T-cells—known as the body's "security guards"—which patrol the system to neutralize other defenders that attack the healthy cells.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "The findings have laid the foundation for a novel area of investigation and spurred the development of new treatments, for instance for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells prevent the system from attacking the growth, so studies are focused on lowering their quantity.

For autoimmune diseases, trials are testing boosting T-reg cells so the body is not under attack. A similar method could also be effective in reducing the chances of transplanted organ failure.

Innovative Studies

Professor Sakaguchi, of Osaka University, performed tests on mice that had their thymus extracted, leading to autoimmune disease.

He showed that introducing immune cells from other mice could stop the illness—suggesting there was a mechanism for blocking immune cells from harming the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic immune disorder in mice and humans that resulted in the discovery of a genetic factor critical for the way regulatory T-cells operate.

"Their groundbreaking work has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly attacking the body's own tissues," said a prominent biological science specialist.

"This work is a striking illustration of how fundamental physiological study can have broad implications for public health."